biolitec Holding GmbH & Co. KG
| ISIN | 🆔 |
|---|---|
| Industry | Medical Technology Optical Fibers Pharmaceutical Products |
| Founded 📆 | March 17 1999 |
| Founder 👔 | |
| Headquarters 🏙️ | Vienna, Austria |
Area served 🗺️ | |
Key people | Dr. Wolfgang Neuberger (Chairman) |
| Members | |
Number of employees | |
| 🌐 Website | biolitec.com |
| 📇 Address | |
| 📞 telephone | |
Biolitec Group or Biolitec Holding GmbH & Co KG is a medical technology company headquartered in Vienna, Austria, specializing in minimally invasive laser applications. The company serves as the parent company of the biolitec Group, which develops and manufactures medical diode lasers and optical fibers.
History and development
The origins of today's biolitec Group date back to 1988, when Dr. Wolfgang Neuberger founded CeramOptec GmbH in Bonn, Germany.[1] The company expanded internationally with branches in the USA (1989) and Malaysia (1991). Initially, CeramOptec developed and produced mainly glass fibers for applications in laser technology, sensor technology, and spectroscopy. Medical laser technology became an increasing focus in subsequent years, leading to the formation of the current biolitec Holding in 1999.[2] Since then, the group of companies has concentrated on developing and producing medical laser systems for minimally invasive treatments in specialized departments such as phlebology, proctology, urology, gynecology, orthopedics, Otorhinolaryngology (ENT), aesthetics, and various other areas of application.
Corporate structure and subsidiaries
The company was publicly traded on the Frankfurt Stock Exchange's Neuer Markt and later on the Entry Standard until 2014.[3] In December 2023, biolitec AG was converted into a limited partnership under the legal name biolitec Holding GmbH & Co. KG.[4] The group includes subsidiaries in medicine, pharmaceuticals, industry, and research, and maintains production and development sites, branches, and distribution partners in Europe, Asia, North America, and South America. The company also operates clinical facilities in Milan, Dubai, and Bangkok that provide minimally invasive laser treatments.
Products and technologies
The biolitec Group develops medical laser systems and fiber-optic technologies for a variety of minimally invasive treatments. Its products are used in:
- Phlebology: treatment of varicose veins[5][6]
- Proctology: treatments for hemorrhoids, anal fistulas, and pilonidal disease[7][8]
- Urology: procedures for benign prostatic hyperplasia, bladder and prostate tumors, and urinary stones[9]
- Gynecology: treatment of ovarian endometriosis, uterine fibroids, and vaginal atrophy[10][11]
- Orthopedics: pain therapy for joints and spine, treatment of herniated discs
- Other areas: ENT medicine, pulmonology, thoracic surgery, and aesthetic procedures
The group also develops devices for regenerative therapy and neurostimulation, as well as components for photodynamic cancer therapy[12]. In addition to medical applications, it produces multimode quartz glass optical fibers for industry, research and medicine.
References
- ↑ "Milestones / Biolitec". biolitec.de. Retrieved 2026-03-26.
- ↑ "Fiber Optic Solutions & Custom Assemblies". CeramOptec. Retrieved 2026-03-26.
- ↑ Dämon, Kerstin (2014-12-19). "Delistings: Diese Unternehmen verabschiedeten sich von der Börse". www.wiwo.de (in Deutsch). Retrieved 2026-03-26.
- ↑ "Firmenbuchauszug von biolitec Holding GmbH & Co KG". firmenbuch.at (in Deutsch). Retrieved 2026-03-26.
- ↑ Hudson, Jocelyn (2022-06-30). "Biolitec launches ELVeS Radial 2ring Swift laser fibre". Venous News. Retrieved 2026-03-26.
- ↑ Verbist, Jürgen; Laeremans, Veerle; Gryffroy, Fien; Van den Eynde, Wouter; Heerinckx, Caroline; Haesen, Dorien (December 2023). "Durability and efficacy of the ELVeS® Radial® 2ring slim fiber for multiple ablations". Phlebology. 38 (10): 641–648. doi:10.1177/02683555231193883. ISSN 1758-1125. PMID 37545129 Check
|pmid=value (help). - ↑ Gys, Ben; De Hous, Nicolas; Hubens, Guy; De Win, Gunter; Komen, Niels (December 2018). "Fistula-tract Laser Closure (FiLaC™) for complex urethroperineal fistula". Acta Chirurgica Belgica. 118 (6): 398–401. doi:10.1080/00015458.2018.1515337. ISSN 0001-5458. PMID 30205751.
- ↑ Elfeki, H.; Shalaby, M.; Emile, S. H.; Sakr, A.; Mikael, M.; Lundby, L. (April 2020). "A systematic review and meta-analysis of the safety and efficacy of fistula laser closure". Techniques in Coloproctology. 24 (4): 265–274. doi:10.1007/s10151-020-02165-1. ISSN 1128-045X. PMID 32065306 Check
|pmid=value (help). - ↑ Ärzteblatt, Deutscher Ärzteverlag GmbH, Redaktion Deutsches (2015-09-10). "Neuer Leonardo HPD-Laser: Schonende Behandlung". Deutsches Ärzteblatt (in Deutsch). Retrieved 2026-03-26.
- ↑ "Neue Lasertherapie vermeidet Narbenbildung bei Myombehandlung | springermedizin.de". www.springermedizin.de (in Deutsch). doi:10.1007/s15013-014-0547-0. Retrieved 2026-03-26.
- ↑ GmbH, Digital Medicine Group-DMG. "biolitec® : Minimal-invasive Lasertherapie bei Vaginalatrophie, Myomen und Endometriose". www.gyn-depesche.de (in Deutsch). Retrieved 2026-03-26.
- ↑ "biolitec-Pharmazeutikum Foscan® erfolgreich in... : Onkologie". Ovid. Retrieved 2026-03-26.
This article "Biolitec Group" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Biolitec Group. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
